New Market Study Published: Bahrain Pharmaceuticals & Healthcare Report Q4 2010

Sept. 25, 2010 - PRLog -- In BMI's Q410 Business Environment Ratings for the 19 countries of the Middle East and Africa region (MEA) region, we find Bahrain moved down one place to occupy fifth position. This adjustment now sees Bahrain placed below Saudi Arabia and above Israel. Bahrain's pharmaceutical rating is 52.6, which is considerably above the average of 45.4 for the region. Although the potential returns from the market are constrained by the island's population of under 1mn, the low-risk economic and political climate and strong pharmaceutical-specific regulatory framework mean that Bahrain is one of the region's most attractive markets in terms of the 'risks to realisation of returns' category.

In 2009, Bahrain's pharmaceutical market was worth just BHD43mn (US$112mn), but this is expected to reach BHD55mn (US$146mn) in 2014. However, BMI expects health spending in Bahrain to increase at a far faster rate, expanding from BHD206mn (US$541mn) in 2009 to BHD486mn (US$1.28bn) by 2014, representing a US dollar compound annual growth rate (CAGR) of 18.8%

As part of efforts to increase public awareness about the prevalence of swine flu, the Ministry of Health launched a website as part of its official e-page. Health Minister Dr. Faisal Al Hamer has stipulated that the http:/H1N1.moh.gov.bh website provide accurate medical information about the disease. The website is also designed to include H1N1 hotlines updates, as well as local, regional and international news and statistics. In addition, the website carries information on pathological symptoms, diagnosis, prevention, and treatment.

In other developments, Bahrain's Prime Minister, Sheikh Khalifa bin Salman Al Khalifa, officially launched one of the country's largest healthcare projects which aims to turn Bahrain into a health oasis 'unique to the region'. The multi-billion dollar Royal College of Surgeons in Ireland (RCSI) Health Oasis facility is to be built on the campus of the Medical University of Bahrain, which is located in the northern town of Busaiteen. The healthcare project will also feature the Oasis Private Hospital, along with other medical centres, a five-star resort and four-star hotel, spas, a wellness centre, a promenade of shops and waterfront cafes, serviced apartments, sports facilities and many other amenities.

Elsewhere, the Bahrain government is to investigate the possibility of establishing a Stem Cell Centre to treat patients with diabetes. A team of experts from Hamburg, Germany, will arrive in Manama to conduct an initial study on the country's needs, as well as suggest ways of setting up the facility. The experts, who are from a company specialising in stem cell research, are to hold discussions with officials at the Ministry of Health, as well as other stakeholders and doctors from the Salmaniya Medical Complex (SMC), who manage and treat patients with diabetes. Discussions will also be held with the Minister of Health, Dr. Al Hamer, during which several decisions are expected to be taken.

For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/83811_bahrain_pharmaceuticals_...

Partial Table of Contents:

Executive Summary
SWOT Analysis
- Bahrain Pharmaceuticals And Healthcare Industry SWOT
- Bahrain Political SWOT
- Bahrain Economic SWOT
- Bahrain Business Environment SWOT
Pharmaceutical Business Environment Ratings
- Table: Middle East And Africa - Regional Pharmaceutical Business Environment Ratings For Q410
- Rewards
- Risks
Bahrain - Market Summary
Regulatory Regime
- Recent Regulatory Developments
- GCC Healthcare Collaboration
- Intellectual Property Developments
- Pricing and Reimbursement Regime
- Regional Price Harmonisation
- Free Trade Agreement with the US
- Other Free Trade Agreements
Industry Developments
- Epidemiology
- Table: Leading Causes Of Death In Bahrain, 2008
- HIV/AIDS
- Healthcare Sector
- Primary, Secondary and Tertiary Healthcare
- Health Insurance
- Table: National Health Insurance Scheme Breakdown
- Strategic Healthcare Goals
- Table: Further Ministry Of Health Objectives
- Healthcare Sector Investment
- Features Of Dilmunia Health Island
- Pharmaceutical Industry - Regional Outlook
- Pharmaceutical Sector
- Pharmaceutical Retail
- Research and Development
- International Collaboration
- Medical Devices
Industry Forecast Scenario
- Overall Market Forecast
- Key Growth Factors - Industry
- Key Growth Factors - Macroeconomic
- Table: Bahrain - Economic Activity, 2007-2014
- Prescription Market Forecast
- Patented Drug Market Forecast
- Generic Drug Market Forecast
- OTC Medicine Market Forecast
- Pharmaceutical Trade Forecast
- Medical Device Market Forecast
- Other Healthcare Data Forecasts
- Key Risks to BMI's Forecast Scenario
Competitive Landscape
Company Monitor
- Indigenous Companies
- Al-Jishi Corporation
- Bahrain Industrial Pharmaceutical Co (Bidapharm)
- Behzad Medical Establishment
- Yousuf Mahmood Husain Company
- Multinational Companies
- GlaxoSmithKline (GSK)
- Novartis
- Johnson & Johnson (J&J)
- Merck & Co
- Pfizer
- Sanofi-Aventis
Country Snapshot: Bahrain Demographic Data
- Section 1: Population
- Table: Demographic Indicators, 2005-2030
- Table: Rural/Urban Breakdown, 2005-2030
-

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=8381...

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.  BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports.  Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports.  View more research from Business Monitor International at http://www.fastmr.com/catalog/publishers.aspx?pubid=1010

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.